IDEAYA Biosciences IDYA
NASDAQ IDYA
$39.77 -0.20 (-0.50%)
As of: Sep 4, 2026 · 2:26 PM EDT

IDEAYA Biosciences (IDYA) Net Margin (QoQ) (2020 - 2026)

Analysis

IDEAYA Biosciences (IDYA) Net Margin (QoQ) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn
5 Revolution Medicines 44.07 Bn 44.07 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn
10 IDEAYA Biosciences 3.66 Bn 2.83 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30,272.00
Mar 31, 2026 -82,917.00
Dec 31, 2025 -91,999.00
Dec 31, 2023 -62,356.00
Sep 30, 2023 50,481.00
Jun 30, 2023 -60,168.00
Mar 31, 2023 31,445.00
Dec 31, 2022 -63,030.00
Sep 30, 2022 39,960.00
Jun 30, 2022 -25,503.00
Mar 31, 2022 49,890.00
Dec 31, 2021 -51,150.00
Sep 30, 2021 -476.00
Jun 30, 2021 -10.00
Mar 31, 2021 -7,620.00
Dec 31, 2020 577.00